Terms: = Leukemia AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Treatment
393 results:
1. AML treatment: conventional chemotherapy and emerging novel agents.
Forsberg M; Konopleva M
Trends Pharmacol Sci; 2024 May; 45(5):430-448. PubMed ID: 38643058
[TBL] [Abstract] [Full Text] [Related]
2. Progress in site-specific cancer mortality in Canada over the last 70 years.
Warkentin MT; Ruan Y; Ellison LF; Billette JM; Demers A; Liu FF; Brenner DR
Sci Rep; 2024 Mar; 14(1):5688. PubMed ID: 38454087
[TBL] [Abstract] [Full Text] [Related]
3. [Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia].
Mizutani Y; Kusakabe S; Fukushima K; Murakami H; Hamada M; Hasegawa C; Mizuta E; Yamaguchi Y; Nakai R; Kurashige R; Hino A; Ueda T; Fujita J; Miyamura T; Hosen N
Rinsho Ketsueki; 2024; 65(2):78-83. PubMed ID: 38448002
[TBL] [Abstract] [Full Text] [Related]
4. [Tyrosine kinase inhibitors for chronic myeloid leukemia].
Réa D
Rev Prat; 2023 Dec; 73(10):1051-1055. PubMed ID: 38294463
[TBL] [Abstract] [Full Text] [Related]
5. fbxw7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1.
Wu X; Iwatsuki M; Takaki M; Saito T; Hayashi T; Kondo M; Sakai Y; Gotohda N; Tanaka E; Nishida T; Baba H
Gastric Cancer; 2024 Mar; 27(2):235-247. PubMed ID: 38142463
[TBL] [Abstract] [Full Text] [Related]
6. fbxw7 affects autophagy through MCL1 in oral squamous cell carcinoma.
Sun Y; Nie W; Qiu B; Yang Q; Zhao H
Oral Dis; 2023 Nov; 29(8):3259-3267. PubMed ID: 38055341
[TBL] [Abstract] [Full Text] [Related]
7. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
[TBL] [Abstract] [Full Text] [Related]
8. Top Ten Contributions of Pediatric Hematology/Oncology to the Diagnosis and treatment of Acute Lymphoblastic leukemia.
Miller DR
J Pediatr Hematol Oncol; 2023 Nov; 45(8):429-435. PubMed ID: 37889043
[TBL] [Abstract] [Full Text] [Related]
9. Knowledge of Palliative Care and Barriers to Access Among Outpatients with Cancer.
Schlichte LM; Hildenbrand J; Wolf S; Herring KW; Troy JD; LeBlanc TW
J Pain Symptom Manage; 2024 Feb; 67(2):115-125. PubMed ID: 37848077
[TBL] [Abstract] [Full Text] [Related]
10. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Safa FM; Rasmussen T; Fontan L; Xia M; Melnick A; Wiestner A; Lobelle-Rich P; Burger JA; Mouawad Y; Safah H; Flemington EK; Saba NS
Haematologica; 2024 May; 109(5):1348-1358. PubMed ID: 37767562
[TBL] [Abstract] [Full Text] [Related]
11. The evolution of payer management of oncology drugs in the United States between 2017 and 2022.
Runyan A; Yi J; Honcz J
J Manag Care Spec Pharm; 2023 Oct; 29(10):1138-1149. PubMed ID: 37695273
[No Abstract] [Full Text] [Related]
12. [Molecular mechanisms of pediatric intractable leukemia].
Takita J
Rinsho Ketsueki; 2023; 64(8):810-815. PubMed ID: 37673635
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)].
Cui CH; Chang YN; Zhou J; Li CW; Wang HJ; Sun Q; Jia YJ; Li QH; Wang TY; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):418-423. PubMed ID: 37550193
[No Abstract] [Full Text] [Related]
14. Back to the future: the amazing journey of the therapeutic anti-leukemia enzyme asparaginase
Tong WH; Rizzari C
Haematologica; 2023 Oct; 108(10):2606-2615. PubMed ID: 37470157
[TBL] [Abstract] [Full Text] [Related]
15. [Current management and new treatment strategies of chronic myeloid leukemia].
Crysandt M; Brümmendorf TH
Dtsch Med Wochenschr; 2023 Jun; 148(12):744-751. PubMed ID: 37257476
[TBL] [Abstract] [Full Text] [Related]
16. A Case Report of Successful Kidney Transplantation in a Patient With Chronic Myelogenous leukemia (CML) Who Has Been in Remission for 15 Years on Imatinib.
Tokumoto T; Setoguchi K; Osaka A; Ikezoe E; Tsujioka H; Hasegawa K; Inoue M; Nirazuka A; Iwahata T; Inoue Y; Saito K
Transplant Proc; 2023 May; 55(4):1074-1077. PubMed ID: 37147192
[TBL] [Abstract] [Full Text] [Related]
17. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Mohty M; Malard F; Alaskar AS; Aljurf M; Arat M; Bader P; Baron F; Bazarbachi A; Blaise D; Brissot E; Ciceri F; Corbacioglu S; Dalle JH; Dignan F; Huynh A; Kenyon M; Nagler A; Pagliuca A; Perić Z; Richardson PG; Ruggeri A; Ruutu T; Yakoub-Agha I; Duarte RF; Carreras E
Bone Marrow Transplant; 2023 Jul; 58(7):749-754. PubMed ID: 37095231
[TBL] [Abstract] [Full Text] [Related]
18. Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia.
Kättström M; Uggla B; Tina E; Kimby E; Norén T; Athlin S
Vaccine; 2023 May; 41(19):3128-3136. PubMed ID: 37061372
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical Study on the Relationship between Gene Mutation Profile and Prognosis in Pediatric Acute Lymphocyte leukemia].
Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
[TBL] [Abstract] [Full Text] [Related]
20. The successful treatment of
Zhou L; Guan Z; Chen C; Zhu Q; Qiu S; Liu Y; Li M; Zeng W; Wang H; Gao Y; Yuan Y; Zhang H; Ruan G; Pan X
Front Cell Infect Microbiol; 2022; 12():1072463. PubMed ID: 36699718
[TBL] [Abstract] [Full Text] [Related]
[Next]
